Newsletter | January 28, 2021

01.28.21 -- How To Ratchet Up Biosimilar Competition In 2021
 
Sponsor
Featured Editorial
Sandoz: Critical Initiatives For The New Canadian “Biosimilars Generation”
 
By Anna Rose Welch, chief editor, Biosimilar Development
Following the launch of “The Biosimilars Generation,” I sat down with Sandoz's Karine Matteau. In addition to sharing the goals of the educational initiative, she also discussed how biosimilar companies and governments can encourage greater biosimilar buy-in among all stakeholders.
Biologics Manufacturing In China: Competition Heats Up Among CMOs
 
By Vicky Qing Xia and Leo Cai Yang, BioPlan Associates, Inc.

Significant growth of outsourced commercial-scale manufacturing is projected for the near future in China, though certain bottlenecks remain.
The Biosimilar Toolbox: How To Ratchet Up Biosimilar Competition In 2021
 
By Anna Rose Welch, chief editor, Biosimilar Development

As you’ll read in the following responses, increased competition in 2021 is on the minds of many. How that competition unfolds has yet to be determined. But if one thing is clear, it’s that the industry has many exciting tools at its disposal to bolster biosimilar competition in 2021. 
Industry Insights
Is Your Biologics At Risk For Protein Aggregation? Part 2
Article | By Martin Gonzalez, Ph.D., Pfizer CentreOne Contract Manufacturing

The manufacture of sterile injectables is fraught with risk, especially when it comes to protein aggregation in biologics drugs. We offer steps you can take to help prevent aggregation.
Why, Why, Why … ELISA? A Look At The Benchmark HCP Assay
Article | By Joe Hirano, Cytiva

Biologics developers and manufacturers demand an accurate and reliable assay for host cell protein (HCP) quantitation. Let’s take a close look at why analytical scientists turn to the ELISA and how it fits into process development.
Can mRNA Disrupt The Biopharma Industry?
White Paper | By Amélie Boulais and Piergiuseppe Nestola, Sartorius Stedim Biotech

mRNA has the potential to revolutionize the field of vaccine development. However, it is critical we understand any factors that could impact its successful entry into today’s market.
News Headlines
Sponsor
Solutions
Methodology For Quality Pharma-Focused Market Research
ISR Reports